Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2025-12-24 @ 7:10 PM
NCT ID: NCT00208403
Eligibility Criteria: Inclusion Criteria: i) Male or female subjects, aged 60 to 75 years (inclusive), and with a weight of less than 100kg. ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained. iii) Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups. iv) Subjects with non-inflammatory arthritis of the hip. v) Subjects who require a primary total hip arthroplasty and are treated at the arthroplasty section of the orthopaedics department at the Investigational Centre. vi) Subjects who are considered suitable for a cemented femoral stem and cemented acetabular component. Exclusion Criteria: i) Subjects who, in the opinion of the Investigator, have an existing condition such as malignancy, severe osteoporosis, disabling musculo-skeletal problems (other than in the hips) or any other condition that would compromise their participation and follow-up in this study. ii) Women who are pregnant. iii) Subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes. iv) Subjects who have participated in a clinical study with an investigational product in the last 6 month(s). v) Subjects who are currently involved in any injury litigation claims. vi) Subjects undergoing corticosteroid treatment. vii) Subjects with any condition for whom the use of conventional bone cement is contra-indicated.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 60 Years
Maximum Age: 75 Years
Study: NCT00208403
Study Brief:
Protocol Section: NCT00208403